Immunoregulation and antidepressant effect of ketamine
Major depressive disorder (MDD) is a common mental health disorder that brings severe disease burden worldwide. Traditional antidepressants are mainly targeted at monoamine neurotransmitters, with low remission rates and high recurrence rates. Ketamine is a noncompetitive glutamate N-methyl-d-aspart...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2021-05-01
|
Series: | Translational Neuroscience |
Subjects: | |
Online Access: | https://doi.org/10.1515/tnsci-2020-0167 |